There’s no doubt that Aussies love a good celebration. We’re all in when it comes to the weekend, and most of us can’t go past a Christmas celebration without a little bit of overindulging. But all this comes at a cost, and it’s taking a massive toll on our waistline.
Novo unlikely to outsource API production for GLP-1s but will stay engaged with fill-finish partners
Novo Nordisk spelled out how it will try to catch up with the extraordinary demand for its GLP-1 drugs, underscoring its rationale for its in-house